{"title":"易普利姆单抗致垂体炎:3例MRI表现。","authors":"Vibhor Wadhwa","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>ypophysitis is a reported compli- cation of ipilimumab, a monoclo- nal antibody which augments T- cell response against tumors. The imaging changes in the pituitary may precede or coincide with the hypopituitarism, but are frequently over- looked due to the subtle alteration in size and en- hancement characteristics. We present a series of 3 patients who developed hypophysitis and pituitary dysfunction subsequent to ipilimumab therapy and describe the MR imaging features and make follow up recommendations.</p>","PeriodicalId":75122,"journal":{"name":"The Journal of the Arkansas Medical Society","volume":"113 11","pages":"270-272"},"PeriodicalIF":0.0000,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ipilimumab Induced Hypophysitis: MRI Findings in a Series of 3 Cases.\",\"authors\":\"Vibhor Wadhwa\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>ypophysitis is a reported compli- cation of ipilimumab, a monoclo- nal antibody which augments T- cell response against tumors. The imaging changes in the pituitary may precede or coincide with the hypopituitarism, but are frequently over- looked due to the subtle alteration in size and en- hancement characteristics. We present a series of 3 patients who developed hypophysitis and pituitary dysfunction subsequent to ipilimumab therapy and describe the MR imaging features and make follow up recommendations.</p>\",\"PeriodicalId\":75122,\"journal\":{\"name\":\"The Journal of the Arkansas Medical Society\",\"volume\":\"113 11\",\"pages\":\"270-272\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of the Arkansas Medical Society\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of the Arkansas Medical Society","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Ipilimumab Induced Hypophysitis: MRI Findings in a Series of 3 Cases.
ypophysitis is a reported compli- cation of ipilimumab, a monoclo- nal antibody which augments T- cell response against tumors. The imaging changes in the pituitary may precede or coincide with the hypopituitarism, but are frequently over- looked due to the subtle alteration in size and en- hancement characteristics. We present a series of 3 patients who developed hypophysitis and pituitary dysfunction subsequent to ipilimumab therapy and describe the MR imaging features and make follow up recommendations.